Advanced Search

 

Study ID Status Title Patient Level Data
200287 Recruiting PH+oeBE - Patterns of care in HER2+ metastatic Breast cancer in large CIS countriEs: A representative, retrospective study in Russian Federation, Ukraine, and Republic of Kazakhstan
200293 Recruiting Drug Use Investigation of RELVAR® (vilanterol trifenatate and fluticasone furoate) for Asthma Patients
200294 Not yet recruiting Special Drug Use Investigation of RELVAR® for Asthma patients
200301 Completed An open-label study of inhaler device attributes investigating critical and overall errors, ease of use, and preference between a number of inhaler devices (ELLIPTA, TURBUHALER, HANDIHALER, BREEZHALER, MDI, and DISKUS/ACCUHALER) in adult subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
200304 Active, Not Recruiting A Phase 3b, randomized, open-label study of the antiviral activity and safety of dolutegravir compared to lopinavir/ritonavir both administered with dual nucleoside reverse transcriptase inhibitor therapy in HIV-1 infected adult subjects with treatment failure on first line therapy
200311 Recruiting Drug Use Investigation of ANORO ELLIPTA inhaler
200312 Not yet recruiting PH+oeBE-Patterns of care in HER2+ metastatic Breast cancer in Europe: patients: A representative, retrospective study in Croatia
200314 Recruiting Registry of subjects treated with Eltrombopag in Mexico
200317 Active, Not Recruiting Belimumab 10mg/kg versus Placebo Post-hoc Analysis of Corticosteroid Use across 52 Weeks of Treament (BLISS-52 & BLISS-76 Meta-analysis)
200318 Recruiting A cohort study to assess the burden of dengue illness in household members from selected communities in Southeast Asia and Latin America
200330 Completed An open-label study of inhaler device attributes investigating critical and overall errors, and ease of use and preference between a number of inhaler devices (ELLIPTA, DISKUS/ACCUHALER, TURBUHALER, and MDI) in adult subjects with asthma (Study 200330)
200331 Recruiting A Phase I, Open-label, Dose-finding Study of GSK2636771 Administered in Combination with Enzalutamide (Xtandi^TM ) in Male Subjects with Metastatic Castration-Resistant Prostate Cancer (mCRPC)
200336 Recruiting ING200336: A Prospective, Interventional Pharmacokinetic and Safety Study of DTG/ABC/3TC in Pregnant Women
200338 Completed An Open-label Single-dose Pharmacokinetic Study of an Oral Formulation in Tablets Containing Eltrombopag 50 mg (Revolade, Glaxosmithkline Mexico, S.A. De C.V.) in Healthy Volunteers Under Fasting Conditions
200339 Completed An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector that Administers Belimumab Subcutaneously in Subjects with Systemic Lupus Erythematosus (SLE) Study Listed on ClinicalStudyDataRequest.com
200341 Completed Evidence Synthesis and Mixed Treatment Comparisons for Evaluating Treatments for Asthma
200342 Completed Evidence Synthesis and Meta-Analysis Framework for Evaluating Treatments for COPD Patients
200344 Terminated A Dose-Escalation, Phase I/II, Open-Label, Three-Part Study of the MEK Inhibitor, trametinib, Combined with the CDK4/6 Inhibitor, palbociclib, To Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Anti-Cancer Activity in Subjects with Solid Tumors
200346 Active, Not Recruiting Direct Cost of Illness Study of Moderate and Severe Asthma in Quebec
200347 Completed Indirect cost of illness study of moderate and severe asthma in Quebec
200363 Active not recruiting An open-label study to characterize the pharmacokinetics and pharmacodynamics of mepolizumab administered subcutaneously in children from 6 to 11 years of age with severe eosinophilic asthma
200367 Completed PGx6951: Analysis of influence of GLCCI1 variant rs37973 on inhaled corticosteroid response in COPD patients treated with fluticasone furoate in HZC112206 and HZC112207
200372 Completed A randomized, open-labelled non-drug interventional, cross-over, dry powder inhaler device preference study to compare “ease of use” of ELLIPTA (TM) inhaler with BREEZHALER (TM) inhaler in inhalation-device naïve Japanese volunteers aged 40 years or older
200374 Not yet recruiting Benefit of patient referral to epilepsy centers in Japan
200381 Completed Post-hoc analysis of Japanese phase II data on initial Parkinson’s disease motor dysfunctions (Study ID: 200381)

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.